controversies in hepatology: checkpoint inhibitors as first line therapy in hcc
Published 4 years ago • 211 plays • Length 24:30Download video MP4
Download video MP3
Similar videos
-
38:48
controversies in hepatology: liver transplantation for cholangiocarcinoma
-
53:05
update in the clinical management of hepatocellular carcinoma
-
48:39
controversies in liver disease
-
58:25
molecular targeted therapies for advanced hcc
-
9:57
first-line and second-line selection of hepatocellular carcinoma under new immunotherapy
-
2:06
dr. llovet on combination therapy in hcc
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
1:01:42
consensus or controversy? immune checkpoint inhibitors in the management of hepatobiliary cancers...
-
57:22
hepatocellular carcinoma: new therapies and challenges
-
55:23
hepatocellular carcinoma: a guide to integrating emerging therapies into current treatment paradigms
-
7:10
evidence with checkpoint inhibition in hcc
-
47:55
evaluating current and emerging targeted therapies in hepatocellular carcinoma
-
54:56
impacting hcc outcomes with multimodal therapy: the importance of interdisciplinary management
-
14:37
how to integrate new agents in hcc: the role of checkpoint inhibitors
-
37:32
updates in hepatocellular carcinoma
-
9:00
how to manage immune checkpoint inhibitor hepatotoxicity
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
43:21
screening and diagnosis of hepatocellular carcinoma
-
1:07:23
treating hepatocellular carcinoma cases with locoregional and systemic therapies